CD22 Antikörper (AA 621-725)
Kurzübersicht für CD22 Antikörper (AA 621-725) (ABIN1724888)
Target
Alle CD22 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
- 
    - 
                                            Bindungsspezifität
- AA 621-725
- 
                                            Verwendungszweck
- CD22 Antibody
- 
                                            Aufreinigung
- Purified antibody
- 
                                            Immunogen
- Purified recombinant fragment of human CD22 (AA: 621-725) expressed in E. Coli.
- 
                                            Isotyp
- IgG1
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- 
                        ELISA: 1/10000 FCM: 1/200 - 1/400 ICC: 1/50 - 1/200 
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Buffer
- Purified antibody in PBS with 0.05 % sodium azide.
- 
                                            Konservierungsmittel
- Sodium azide
- 
                                            Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Lagerung
- 4 °C,-20 °C
- 
                                            Informationen zur Lagerung
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
 
- 
                                            
- 
    - 
                                            : "CD22 antigen is broadly expressed on lung cancer cells and is a target for antibody-based therapy."    in: Cancer research, Vol. 72, Issue 21, pp. 5556-65, (2012)         (PubMed).        
 : "CD22 regulates adaptive and innate immune responses of B cells." in: Journal of innate immunity, Vol. 3, Issue 4, pp. 411-9, (2011) (PubMed).
 
 
- 
                                            : "CD22 antigen is broadly expressed on lung cancer cells and is a target for antibody-based therapy."    in: Cancer research, Vol. 72, Issue 21, pp. 5556-65, (2012)         (PubMed).        
- 
    - CD22 (CD22 Molecule (CD22))
- 
                                            Andere Bezeichnung
- CD22
- 
                                            Hintergrund
- 
                        CD22 may be involved in the localization of B-cells in lymphoid tissues. Binds sialylated glycoproteins, one of which is CD45. Preferentially binds to alpha-2,6-linked sialic acid. The sialic acid recognition site can be masked by cis interactions with sialic acids on the same cell surface. Upon ligand induced tyrosine phosphorylation in the immune response seems to be involved in regulation of B-cell antigen receptor signaling. Plays a role in positive regulation through interaction with Src family tyrosine kinases and may also act as an inhibitory receptor by recruiting cytoplasmic phosphatases via their SH2 domains that block signal transduction through dephosphorylation of signaling molecules 
 
- 
                                            Molekulargewicht
- 95.3 kDa
- 
                                            Gen-ID
- 933
- 
                                            UniProt
- P20273
 Target
- 
                    
 
                                     
                                     
                                    